IN2013MU03639A - - Google Patents

Info

Publication number
IN2013MU03639A
IN2013MU03639A IN3639MU2013A IN2013MU03639A IN 2013MU03639 A IN2013MU03639 A IN 2013MU03639A IN 3639MU2013 A IN3639MU2013 A IN 3639MU2013A IN 2013MU03639 A IN2013MU03639 A IN 2013MU03639A
Authority
IN
India
Prior art keywords
agomelatine
amorphous form
stable
stable amorphous
pharmaceutical composition
Prior art date
Application number
Other languages
English (en)
Inventor
Pankajkumar Maneklal Khapra
Dipankar DasuRanjan Bhadra
Hitesh Vaikunthbhai Thakkar
Rohan Aminbhai Lalani
Original Assignee
Alembic Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Pharmaceuticals Ltd filed Critical Alembic Pharmaceuticals Ltd
Priority to IN3639MU2013 priority Critical patent/IN2013MU03639A/en
Publication of IN2013MU03639A publication Critical patent/IN2013MU03639A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN3639MU2013 2013-11-20 2013-11-20 IN2013MU03639A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3639MU2013 IN2013MU03639A (ja) 2013-11-20 2013-11-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3639MU2013 IN2013MU03639A (ja) 2013-11-20 2013-11-20

Publications (1)

Publication Number Publication Date
IN2013MU03639A true IN2013MU03639A (ja) 2015-07-31

Family

ID=54397614

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3639MU2013 IN2013MU03639A (ja) 2013-11-20 2013-11-20

Country Status (1)

Country Link
IN (1) IN2013MU03639A (ja)

Similar Documents

Publication Publication Date Title
PH12016501122A1 (en) Delayed release compositions of linaclotide
EP3206706A4 (en) Stable injectable composition of pharmaceutically active agents and process for its preparation
PT3027186T (pt) Processo para a preparação de composições compreendendo ácido hialurónico e cloridrato de mepivacaína
MD20170048A2 (ro) Formulare pe bază de acetat de abirateronă şi procedee de utilizare a acesteia
IN2013MU03583A (ja)
MX2018013742A (es) Formas cristalinas de crisaborol en forma libre, metodo de preparacion y uso de las mismas.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2015011109A (es) Composiciones estables de activador de glucoquinasa.
IN2013MU03641A (ja)
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
IL239958A0 (en) A chewable preparation for oral care and a process for its preparation
EP3311809A4 (en) USE OF A PHARMACEUTICAL COMPOSITION IN THE PREPARATION OF A MEDICAMENT FOR PROMOTING CHONDROCYTE PRODUCTION
EP2978421A4 (en) STABLE NANOCOMPOSITION COMPRISING DOCATEXEL, PROCESS FOR PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IN2013MU01111A (ja)
GB2527233A (en) Composition comprising hydrocortisone
IN2013CH04314A (ja)
IN2013MU03428A (ja)
IN2013MU03639A (ja)
ZA201506665B (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
ZA201506656B (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
IN2013MU01226A (ja)
IN2013MU02111A (ja)
IN2013MU02110A (ja)